Community pharmacists' knowledge, attitude, and practice of Irritable Bowel Syndrome (IBS): the impact of training courses

被引:3
|
作者
Mahmoudi, Laleh [1 ]
Shafiekhani, Mojtaba [1 ]
Dehghanpour, Hamed [1 ]
Niknam, Ramin [2 ]
机构
[1] Shiraz Univ Med Sci, Sch Pharm, Dept Clin Pharm, Shiraz, Iran
[2] Shiraz Univ Med Sci, Gastroenterohepatol Res Ctr, Shiraz, Iran
关键词
attitude; practice; knowledge; Irritable Bowel Syndrome; pharmacist; PRIMARY-CARE; PHYSICIANS;
D O I
10.2147/AMEP.S201904
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Introduction: Irritable Bowel Syndrome (IBS) is a common chronic functional gastrointestinal disorder. Pharmacists have a vital role in patient education and in drug-therapy management for IBS. This survey is the first study in Iran, to evaluate knowledge, attitude, and practice (KAP) of community pharmacists on IBS, and the impact of training courses on the improvement of their skills. Objective and setting: This pre- and post-cross-sectional study was conducted to evaluate IBS-KAP amongst Community pharmacists in Shiraz, Iran. Methods: Pretested questionnaires were designed to assess professional characteristics and KAP components of the community pharmacists regarding IBS. All pharmacists from Shiraz were invited to participate in a 3-day training course on IBS. The participants were requested to complete the questionnaire before commencing the training course (pre-test), at the end of the 3-days course (post-test), and also 3 months after the course (follow-up test). Results: Correct answers to all parts increased after the training course, as well as in the follow-up stage, which was statistically significant in all three parts (P<0.05). The increases in correct answers were seen in the fields of attitude, practice, and knowledge. Conclusion: It seems that continuing IBS training courses are essential for pharmacists, regarding the fact that they can play an important role in assisting patients with IBS, as they are easily accessible healthcare professionals.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 50 条
  • [41] Placebo responses in studies with irritable bowel syndrome (IBS)
    Klosterhalfen, S.
    Enck, P.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2006, 61 (03) : 401 - 401
  • [42] Symptom Episode Patterns in Irritable Bowel Syndrome (IBS)
    Palsson, Olafur S.
    Baggish, Jeffrey S.
    Whitehead, William E.
    GASTROENTEROLOGY, 2013, 144 (05) : S919 - S919
  • [43] DIMINISHED COLONIC SEGMENTATION IN THE IRRITABLE BOWEL SYNDROME (IBS)
    TROTMAN, IF
    MISIEWICZ, JJ
    GASTROENTEROLOGY, 1984, 86 (05) : 1283 - 1283
  • [44] Tryptophan depletion study in irritable bowel syndrome (IBS)
    Shufflebotham, J
    Hood, S
    Potokar, J
    Probert, C
    GASTROENTEROLOGY, 2004, 126 (04) : A372 - A372
  • [45] Tryptophan depletion study in irritable bowel syndrome (IBS)
    Shufflebotham, J
    Hendry, J
    Rich, A
    Probert, C
    Nutt, D
    Potokar, J
    Hood, S
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A17 - A17
  • [46] IRRITABLE BOWEL SYNDROME (IBS) - CLINICAL AND PSYCHOMETRIC ASSESSMENT
    VAUGHAN, SL
    MEARES, RA
    MASHFORD, ML
    ISER, JH
    SMALLWOO.RA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1974, 4 (03): : 306 - 306
  • [47] Relationship between dysthymia and irritable bowel syndrome (IBS)
    Masand, PS
    Kaplan, D
    Gupta, S
    Bhandary, A
    PSYCHOSOMATICS, 1996, 37 (02) : 22 - 22
  • [48] Knowledge, attitude, and practice of healthcare professionals towards irritable bowel syndrome: a multicenter, cross-sectional study
    Wang, Tingjun
    Wu, Chen
    Wang, Lingyun
    Tang, Yanyan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [49] Medicines taken by patients with irritable bowel syndrome (IBS)
    Kinnear, M
    Steinke, D
    Smith, G
    Penman, ID
    GUT, 2003, 52 : A85 - A85
  • [50] ABDOMINAL BLOATING IN THE IRRITABLE-BOWEL-SYNDROME (IBS)
    CATNACH, SM
    DEWSNAP, P
    HERDMAN, M
    LIBBY, G
    FARTHING, MJG
    FAIRCLOUGH, PD
    GUT, 1990, 31 (10) : A1171 - A1172